A novel point mutation in exon 20 of EGFR showed sensitivity to erlotinib.
Xing K, Zhou X, Zhao X, Sun S, Luo Z, Wang H, Yu H, Wang J, Chang J, Wu X, Hu A.
Xing K, et al. Among authors: wang h, wang j.
Med Oncol. 2014 Jul;31(7):36. doi: 10.1007/s12032-014-0036-2. Epub 2014 Jun 8.
Med Oncol. 2014.
PMID: 24908064